adamantylamide-alanyl-isoglutamine and B cepacia Infection

adamantylamide-alanyl-isoglutamine has been researched along with B cepacia Infection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aranibar Urey, RC; Bertot, GM; Galanternik, L; Grinstein, S; Restelli, MA; Valvano, MA	1

Other Studies

1 other study(ies) available for adamantylamide-alanyl-isoglutamine and B cepacia Infection

Article	Year
Nasal immunization with Burkholderia multivorans outer membrane proteins and the mucosal adjuvant adamantylamide dipeptide confers efficient protection against experimental lung infections with B. multivorans and B. cenocepacia. Infection and immunity, 2007, Volume: 75, Issue:6 Topics: Adjuvants, Immunologic; Administration, Intranasal; Amantadine; Animals; Antibodies, Bacterial; Bacterial Outer Membrane Proteins; Burkholderia cepacia complex; Burkholderia Infections; Dipeptides; Disease Models, Animal; Immunization; Lung Diseases; Mice; Mice, Inbred BALB C	2007

Article

Year

Nasal immunization with Burkholderia multivorans outer membrane proteins and the mucosal adjuvant adamantylamide dipeptide confers efficient protection against experimental lung infections with B. multivorans and B. cenocepacia.

Infection and immunity, 2007, Volume: 75, Issue:6

Topics: Adjuvants, Immunologic; Administration, Intranasal; Amantadine; Animals; Antibodies, Bacterial; Bacterial Outer Membrane Proteins; Burkholderia cepacia complex; Burkholderia Infections; Dipeptides; Disease Models, Animal; Immunization; Lung Diseases; Mice; Mice, Inbred BALB C

2007